Post-exercise Heart Rate Recovery in HIV-positive Individuals on Highly Active Antiretroviral Therapy. Early Indicator of Cardiovascular Disease?

Overview

Journal HIV Med

Publisher Wiley

Specialty Infectious Diseases

Date 2007 Dec 21

PMID 18093131

Citations 13

Authors

W T Cade

D N Reeds

S Lassa-Claxton

V G Davila-Roman

A D Waggoner

W G Powderly

K E Yarasheski

Affiliations

Soon will be listed here.

Abstract

Background: HIV infection and its treatment, specifically protease inhibitor (PI) therapy, have been associated with an increased risk for cardiovascular disease. Heart rate recovery (HRR) following peak exercise is predictive of future cardiovascular events and mortality in the general population. Nothing is known regarding HRR in individuals infected with HIV on highly active antiretroviral therapy (HAART).

Subjects And Methods: HIV-positive subjects on HAART that included a PI (HIV+PI, n=19), HIV-positive subjects on HAART that did not include a PI (HIV+noPI, n=19) and HIV-seronegative age, gender and body mass index (BMI) matched controls (Cntl, n=15) underwent a graded maximal exercise test on a cycle ergometer to volitional exhaustion. A continuous electrocardiogram was recorded and HRR was monitored every 30 s for 2 min post exercise.

Results: HRR at 1.5 and 2 min was significantly delayed in HIV-positive subjects both on and not on PI-based HAART compared with controls (P<0.01).

Conclusion: HRR is impaired in HIV-positive individuals on HAART, whether or not the HAART includes a PI, compared with age, gender, BMI, and activity level matched HIV-seronegative controls. Abnormal HRR may reflect cardio-autonomic dysfunction and may be an independent risk factor for future cardiac events in HIV-positive individuals that receive HAART.

Citing Articles

Association of chronotropic incompetence with reduced cardiorespiratory fitness in older adults with HIV.

Oursler K, Briggs B, Lozano A, Harris N, Parashar A, Ryan A AIDS. 2024; 38(6):825-833.

PMID: 38578959 PMC: 11003719. DOI: 10.1097/QAD.0000000000003840.

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors.

Okafor S, Meyer A, Gadsden J, Ahmed F, Guzman L, Ahmed H Molecules. 2023; 28(17).

PMID: 37687159 PMC: 10488881. DOI: 10.3390/molecules28176330.

Autonomic Neuropathy as a Predictor of Morbidity and Mortality in People Living With HIV: A Retrospective, Longitudinal Cohort Study.

Kwon P, Lawrence S, Figueroa A, Robinson-Papp J Neurol Clin Pract. 2023; 13(3):e200141.

PMID: 37066108 PMC: 10092299. DOI: 10.1212/CPJ.0000000000200141.

Linear and non-linear analysis of heart rate variability in HIV-positive patients on two different antiretroviral therapy regimens.

Goncalves A, Braga M, Santana P, Resende L, da Silva V, Correia D BMC Infect Dis. 2021; 21(1):1022.

PMID: 34587909 PMC: 8482565. DOI: 10.1186/s12879-021-06648-w.

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

Nzuza S, Zondi S, Owira P PLoS One. 2017; 12(11):e0183355.

PMID: 29121676 PMC: 5679664. DOI: 10.1371/journal.pone.0183355.

References

Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm D . A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998; 12(7):F51-8. DOI: 10.1097/00002030-199807000-00003. View

Calza L, Manfredi R, Chiodo F . Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother. 2003; 53(1):10-4. DOI: 10.1093/jac/dkh013. View

Pierpont G, Stolpman D, Gornick C . Heart rate recovery post-exercise as an index of parasympathetic activity. J Auton Nerv Syst. 2000; 80(3):169-74. DOI: 10.1016/s0165-1838(00)00090-4. View

Correia D, Rodrigues De Resende L, Molina R, Ferreira B, Colombari F, Barbosa C . Power spectral analysis of heart rate variability in HIV-infected and AIDS patients. Pacing Clin Electrophysiol. 2006; 29(1):53-8. DOI: 10.1111/j.1540-8159.2006.00297.x. View

Passalaris J, Sepkowitz K, Glesby M . Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis. 2000; 31(3):787-97. DOI: 10.1086/313995. View

Vivekananthan D, Blackstone E, Pothier C, Lauer M . Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol. 2003; 42(5):831-8. DOI: 10.1016/s0735-1097(03)00833-7. View

Lauer M, Sivarajan Froelicher E, Williams M, Kligfield P . Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2005; 112(5):771-6. DOI: 10.1161/CIRCULATIONAHA.105.166543. View

Reeds D, Yarasheski K, Fontana L, Cade W, Laciny E, DeMoss A . Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia. Am J Physiol Endocrinol Metab. 2005; 290(1):E47-E53. DOI: 10.1152/ajpendo.00236.2005. View

Lipinski M, Vetrovec G, Froelicher V . Importance of the first two minutes of heart rate recovery after exercise treadmill testing in predicting mortality and the presence of coronary artery disease in men. Am J Cardiol. 2004; 93(4):445-9. DOI: 10.1016/j.amjcard.2003.10.039. View

10.

Longo-Mbenza B, Seghers L, Vita E, Tonduangu K, Bayekula M . Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study. Heart. 1998; 80(2):184-9. PMC: 1728784. DOI: 10.1136/hrt.80.2.184. View

11.

Mittal C, Wig N, Mishra S, Deepak K . Heart rate variability in human immunodeficiency virus-positive individuals. Int J Cardiol. 2004; 94(1):1-6. DOI: 10.1016/j.ijcard.2003.02.002. View

12.

Yarasheski K, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J . Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr. 1999; 21(3):209-16. PMC: 3182110. DOI: 10.1097/00126334-199907010-00005. View

13.

Jouven X, Empana J, Schwartz P, Desnos M, Courbon D, Ducimetiere P . Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005; 352(19):1951-8. DOI: 10.1056/NEJMoa043012. View

14.

Spies C, Otte C, Kanaya A, Pipkin S, Schiller N, Whooley M . Association of metabolic syndrome with exercise capacity and heart rate recovery in patients with coronary heart disease in the heart and soul study. Am J Cardiol. 2005; 95(10):1175-9. PMC: 2776681. DOI: 10.1016/j.amjcard.2005.01.045. View

15.

Friis-Moller N, Sabin C, Weber R, Monforte A, El-Sadr W, Reiss P . Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003; 349(21):1993-2003. DOI: 10.1056/NEJMoa030218. View

16.

Cheng Y, Lauer M, Earnest C, Church T, Kampert J, Gibbons L . Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes. Diabetes Care. 2003; 26(7):2052-7. DOI: 10.2337/diacare.26.7.2052. View

17.

Fu W, Chai H, Yao Q, Chen C . Effects of HIV protease inhibitor ritonavir on vasomotor function and endothelial nitric oxide synthase expression. J Acquir Immune Defic Syndr. 2005; 39(2):152-8. View

18.

Zhong D, Lu X, Conklin B, Lin P, Lumsden A, Yao Q . HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol. 2002; 22(10):1560-6. DOI: 10.1161/01.atv.0000034707.40046.02. View

19.

Lauer M, Francis G, Okin P, Pashkow F, Snader C, Marwick T . Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA. 1999; 281(6):524-9. DOI: 10.1001/jama.281.6.524. View

20.

Srivastava R, Blackstone E, Lauer M . Association of smoking with abnormal exercise heart rate responses and long-term prognosis in a healthy, population-based cohort. Am J Med. 2000; 109(1):20-6. DOI: 10.1016/s0002-9343(00)00441-1. View